Stocks Rise on Tech Earnings, Pfizer's RSV Vaccine

U.S. stocks start positively, with investors awaiting Federal Reserves interest rate decision. Oracle and Adobes earnings reports influence market sentiment. Pfizers RSV vaccine trial results boost pharmaceutical stocks. Apples iPhone production slowdown impacts tech shares, while Teslas CEO Elon Musks statement on record vehicle deliveries boosts electric car makers stocks.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.